Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Global Avian Influenza Vaccines Sales Market Revenue Status and Forecast to 2022

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

This press release was orginally distributed by SBWire

City of Industry, CA -- (SBWIRE) -- 06/13/2018 -- This report studies the global Avian Influenza Vaccines market status and forecast, categorizes the global Avian Influenza Vaccines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/492991/global-avian-influenza-vaccines-sales-market

The global average price of Avian Influenza Vaccines is in the decreasing trend, from 20 K USD/K doses in 2011 to 19.8 USD/K doses in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Avian Influenza Vaccines includes H5 Avian Influenza Vaccines, H9 Avian Influenza Vaccines and other Avian Influenza Vaccines, and the proportion of H5 Avian Influenza Vaccines in 2015 is about 73%, and the proportion is in decreasing trend from 2011 to 2015.

Avian Influenza Vaccines is widely used in Chicken, Duck & Goose and Other birds. The most proportion of Avian Influenza Vaccines is used in chicken, and the production proportion in 2015 is about 77%.

China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49% in 2015. Asia (Ex. China) is the second largest supplier of Avian Influenza Vaccines, enjoying production market share nearly 23% in 2015.

China is the largest consumption place, with a consumption market share nearly 45% in 2015. Following China, Asia (Ex. China) is the second largest consumption place with the consumption market share of 26%.

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/492991/global-avian-influenza-vaccines-sales-market

Market competition is intense. Merial, QYH Biotech, DHN, HVRI, CEVA, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Avian Influenza Vaccines market is valued at 100 million US$ in 2017 and will reach 130 million US$ by the end of 2025, growing at a CAGR of 2.4% during 2018-2025.

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.

For more information on this press release visit: http://www.sbwire.com/press-releases/global-avian-influenza-vaccines-sales-market-revenue-status-and-forecast-to-2022-994336.htm

Media Relations Contact

Rahul Singh
Director - Digital Marketing
QY Research, Inc
Telephone: 1-626-295-2442
Email: Click to Email Rahul Singh
Web: https://www.qyresearch.com/index/detail/492991/global-avian-influenza-vaccines-sales-market